James Tulsky receives award from American Cancer Society

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

JAMES TULSKY received the Pathfinder in Palliative Care Award from the American Cancer Society.

Tulsky is chief of Duke Palliative Care and professor of medicine and nursing at Duke University.

Presented at the Kathleen Foley Palliative Care Research Retreat, the award recognizes innovation and ingenuity in contributing to the advancement of the palliative care field. Tulsky received the award for his work on oncologist-patient communication; being an advocate for palliative and supportive care research; and his mentorship of faculty in palliative care research.

In the 1990s, Tulsky was the first to examine how residents and faculty talk to patients about resuscitative choices. His landmark study identified major deficiencies in communication and he became a leader in developing interventions to improve clinician communication skills. This led to the development of an NCI-funded online intervention which improved the oncologist’s ability to identify and respond to empathic opportunities and improved trust between clinician and patient.

He was also a member of the Institute of Medicine committee that recently authored the study on “Dying in America,” which recommended major changes to care for seriously ill patients.

YOU MAY BE INTERESTED IN

Physician-scientists by day, a funk-loving musical troupe by night. You may have seen The CheckPoints—a 13 member cover band with a three-piece brass section and Jim Allison on harmonica—movin’, groovin’, and gettin’ down as a mainstay closing act at ASCO, AACR, or the Society for Immunotherapy of Cancer annual meetings. 
At the 2026 Annual Meeting of the American Society of Clinical Oncology in Chicago, results from the phase III HARMONi-6 trial were presented at the plenary session and published simultaneously in The Lancet. The HARMONi-6 trial tested a novel bispecific antibody that engages PD-1 and VEGF (ivonescimab), given with platinum-doublet chemotherapy to patients with previously untreated advanced squamous non-small cell lung cancer. 
In 2026, more than 900 million people are estimated to be regularly using generative artificial intelligence—computer systems capable of creating human-like text, images, audio, video, and other original content. AI is becoming integrated into nearly every aspect of daily life. Health care is no exception. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login